PF icon
Feature Partner

Universal Ibogaine

Quick Overview of Universal Ibogaine

Company Status
Public
Private
Non-Profit
Parent Company
CSE Ticker
FSE TICKER
OTC Ticker
TSX TICKER
IBO
TSX Venture TICKER
NEO TICKER
NASDAQ TICKER
NYSE TICKER

Company Summary

About

Universal Ibogaine is a life sciences company, with a goal to develop a platform of addiction treatment clinics, which may eventually use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants.  

UI separately plans to clinically develop ibogaine, a natural plant substance, as an authorized addiction interruption medicine for the treatment of Opioid Use Disorder.  A Clinical Trial Application to Health Canada is being developed to undertake clinical trials in Canada, aimed at proving the safety and efficacy of the use of ibogaine for this purpose.  In the longer term, UI plans to introduce ibogaine into the addiction treatment protocols to be used in its’ future facilities.